Buy CRSP by Aug 31, 2026.

2023–2026: “AI will change the world.” 2027–2035: “Have you updated your DNA yet?” Sounds like science fiction, but companies like $CRSP, $NTLA, and $BEAM are already working on gene-editing therapies that could potentially treat inherited diseases by modifying DNA itself. Meanwhile, $ILMN is building the infrastructure behind the industry, developing the sequencing technologies that allow scientists to read and analyze genetic code. AI works with data. Genetics works with the source code of life. Markets love big narratives: the Internet, …